GenapSys

Sigma-Aldrich has been developing reagents for the Genius platform for about a year.

This article was originally published February 17.

NEW YORK (GenomeWeb News) –GenapSys said today that it has raised $37 million in a Series B financing round to support commercialization of its next-generation sequencing platform.

NEW YORK (GenomeWeb News) – DNA sequencing technologies startup GenapSys has raised $8.5 million of a target goal of $13.6 million, the company disclosed in a document recently filed with the US Securities and Exchange Commission.

Informatics startup Syapse said this week that it has raised $3 million in Series A venture capital funding to support continued development of software for use in next-generation sequencing-based diagnostics.

People In The News

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

This article has been updated with additional information from GenapSys.

Genapsys has expanded its management team and scientific advisory board.

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute said today that it has pumped $19 million into new research and development projects that seek to bring down the costs of DNA sequencing.

By Julia Karow
GenapSys of Menlo Park, Calif., is developing a DNA sequencing instrument that will be based on label-free nanosensor array technology.

Pages

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.